Radiopharm Theranostics CEO and Managing Director Riccardo Canevari, Chief Medical Officer Dr. David Mozley, and Executive Chairman Paul Hopper joined Proactive to discuss its latest advancements and current understanding of the radiopharmaceutical area.
The Perth, Australia-based group is developing a platform of radiopharmaceutical and nuclear medicine products for both diagnostic and therapeutic uses.